(D-Leu7)-LHRH, also known as (D-Leucine^7)-Luteinizing Hormone-Releasing Hormone, is a synthetic analog of the naturally occurring gonadotropin-releasing hormone (GnRH). This peptide is characterized by the substitution of the seventh amino acid, leucine, with its D-enantiomer, which enhances its stability and bioactivity. The compound plays a crucial role in regulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland, thereby influencing reproductive functions. Its structure typically consists of a sequence of amino acids that includes a modified terminal, contributing to its increased resistance to enzymatic degradation. (D-Leu7)-LHRH is utilized in various biomedical applications, including fertility treatments and hormone-related therapies. Additionally, it has been studied for its potential in treating hormone-sensitive cancers due to its ability to modulate hormone levels. As a synthetic peptide, it is usually administered via injection and is subject to strict regulatory controls in clinical settings.

(D-Leu7)-Lhrh

53728-75-9: (D-Leu7)-LHRH, also known as (D-Leucine^7)-Luteinizing Hormone-Releasing Hormone, is a synthetic analog of the naturally occurring gonadotropin-releasing hormone (GnRH). This peptide is characterized by the substitution of the seventh amino acid, leucine, with its D-enantiomer, which enhances its stability and bioactivity. The compound plays a crucial role in regulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland, thereby influencing reproductive functions. Its structure typically consists of a sequence of amino acids that includes a modified terminal, contributing to its increased resistance to enzymatic degradation. (D-Leu7)-LHRH is utilized in various biomedical applications, including fertility treatments and hormone-related therapies. Additionally, it has been studied for its potential in treating hormone-sensitive cancers due to its ability to modulate hormone levels. As a synthetic peptide, it is usually administered via injection and is subject to strict regulatory controls in clinical settings.

(D-Leu⁷)-LHRH

<p>Please enquire for more information about (D-Leu7)-LHRH trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 53728-75-9

(D-Leu7)-Lhrh

(D-Leu⁷)-LHRH

Ref: 01-4041861

(D-Leu7)-LHRH trifluoroacetate salt

Ref: 3D-FL109670